Celsion Corporation, based in Lawrence Township, NJ, is a biotech company that specializes in developing innovative medicines that work in harmony with the body's immune system. Their breakthroughs are centered around harnessing the building blocks of life, such as immunology and DNA-based platforms, to address some of the most challenging medical conditions. With a team of experienced senior executives and key partnerships with renowned research institutions, Celsion is dedicated to solving the world's biggest healthcare problems, including vaccine-preventable diseases and cancer.
Under the leadership of President and CEO Corinne Le Goff, who brings extensive experience in global healthcare and successful drug development, Celsion is committed to creating life-saving therapies. Their pipeline consists of products targeting a market worth $15 billion, with a focus on anti-cancer nucleic acid-based therapies and nucleic acid vaccines for infectious diseases and cancer. By prioritizing bold solutions and the opportunity for every individual to live a full life, Celsion is at the forefront of advancing medical science and improving patient outcomes.
Generated from the website